Characterizing treatment interruptions in the OPERA cohort and virologic outcomes after resumption with bictegravir/emtricitabine/tenofovir alafenamide.
Saved in:
| Title: | Characterizing treatment interruptions in the OPERA cohort and virologic outcomes after resumption with bictegravir/emtricitabine/tenofovir alafenamide. |
|---|---|
| Authors: | Mounzer, Karam1 (AUTHOR), Osterman, Michael D.2 (AUTHOR) michael.osterman@epividian.com, Brunet, Laurence2 (AUTHOR), Hsu, Ricky K.3 (AUTHOR), Pierone Jr., Gerald4 (AUTHOR), Fusco, Jennifer S.2 (AUTHOR), Prata Menezes, Neia5 (AUTHOR), Gruber, Joshua5 (AUTHOR), Lim, Travis5 (AUTHOR), Dunbar, Megan5 (AUTHOR), Fusco, Gregory P.2 (AUTHOR) |
| Source: | AIDS Research & Therapy. 7/21/2025, Vol. 22 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17426405 |
|---|---|
| DOI: | 10.1186/s12981-025-00769-x |
